Pathogenesis of interstitial lung disease in children and adults
SW Glasser, WD Hardie, JS Hagood - … allergy, immunology, and …, 2010 - liebertpub.com
Interstitial lung diseases (ILDs) occur across the lifespan, from birth to advanced age.
However, the causes, clinical manifestations, histopathology, and management of ILD differ …
However, the causes, clinical manifestations, histopathology, and management of ILD differ …
The effect of nasal continuous positive airway pressure after administration of surfactant on less than 32 week old preterm newborns with respiratory distress …
M Heidarzadeh, A Safaralizadeh… - Journal of Arak …, 2010 - jams.arakmu.ac.ir
Background: Among respiratory support techniques, nasal continuous positive airway
pressure (NCPAP) and mechanical ventilation (MV) are more known for their effectivity in …
pressure (NCPAP) and mechanical ventilation (MV) are more known for their effectivity in …
Surfactant deficiency disorders: SP-B and ABCA3
LM Nogee - Molecular Basis of Pulmonary Disease: Insights from …, 2010 - Springer
Single gene disorders disrupting surfactant metabolism and resulting in acute and chronic
lung disease have been identified in recent years. This review focuses on lung disease …
lung disease have been identified in recent years. This review focuses on lung disease …
Structures and interactions of lung surfactant protein B (SP-B) peptides
M Sarker - 2010 - research.library.mun.ca
Lung surfactant is a complex mixture of lipids and proteins that enables normal breathing by
reducing the surface tension at the alveolar air-water interface, and additionally provides the …
reducing the surface tension at the alveolar air-water interface, and additionally provides the …